Arthritis drug Actemra in short supply as demand for use in COVID ramps up
By
Alicia Lasek
Aug 18, 2021
Demand for Actemra IV has skyrocketed due to the latest wave of COVID-19 infections and hospitalizations, drugmaker Genentech says. In the past two weeks alone, orders for the drug shot up to 400% of pre-COVID...